Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that. Top News .

MONDAY, Sept. 16, 2024 (HealthDay News) -- Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic ...

The Canadian researcher has just received the Frontiers of Knowledge Award for his work on anti-obesity drugs. However, he ...

They also lost weight and had better liver function. THURSDAY, May 1, 2025 (HealthDay News) -- The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new ...

Ozempic, a diabetes drug, shows promise for liver disease. Research indicates it can reverse non-alcoholic steatohepatitis. A study reveals significan ...

Drugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study. Researchers administered weekly injections — either a placebo or ...

New research published Tuesday concludes that the rising rate of extreme childhood obesity—well above the usual BMI ...

Researchers have drawn a connection between Ozempic and the prevention of liver diseases in specific patients. Getty Images/iStockphoto That sample was then divided into those who had taken GLP-1 ...

They also lost weight and had better liver function. THURSDAY, May 1, 2025 (HealthDay News) -- The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new ...

THURSDAY, May 1, 2025 (HealthDay News) -- The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has found. Nearly twice as many ...